AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BRIMONIDINE TARTRATE/TIMOLOL MALEATE

11 registrations across 2 African markets— 11 active

Markets with BRIMONIDINE TARTRATE/TIMOLOL MALEATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
TIMONIDIN OPHTHALMIC SOLUTION (Each ml contains Brimonidine Tartrate/Timolol Maleate 0.2% w/v, 0.5% w/v)🇬🇭GhanaactiveJul 2030
TIMONIDIN OPHTHALMIC SOLUTION🇬🇭GhanaactiveJul 2030
TIMONIDIN OPHTHALMIC SOLUTION🇬🇭GhanaactiveJul 2030
TIMONIDIN OPHTHALMIC SOLUTION (Each ml contains Brimonidine Tartrate/Timolol Maleate 0.2% w/v, 0.5% w/v)🇬🇭GhanaactiveJul 2030
C-PRES​ ​EYE DROP🇬🇭GhanaactiveMar 2030
C-PRES​ ​EYE DROP🇬🇭GhanaactiveMar 2030
COMBIGAN EYE DROPS🇬🇭GhanaactiveOct 2029
COMBIGAN EYE DROPS🇬🇭GhanaactiveOct 2029
BRIMODROP-T EYE DROPS (Each ml contains: Brimonidine Tartrate/Timolol Maleate 2mg+5mg/ml)🇬🇭GhanaactiveDec 2028
BRIMODROP-T EYE DROPS (Each ml contains: Brimonidine Tartrate/Timolol Maleate 2mg+5mg/ml)🇬🇭GhanaactiveDec 2028
COMBIGAN
SOLUTION
🇿🇼ZimbabweABBVIE PTY LTDactiveDec 2027

BRIMONIDINE TARTRATE/TIMOLOL MALEATE in Africa — Regulatory Overview

BRIMONIDINE TARTRATE/TIMOLOL MALEATE is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.